555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [xổ số chủ nhật tuần trước]
On November 12, 2021, a Chinese court entered a 2.46-billion-yuan ($385.26 million) verdict in a collective investor action against Kangmei Pharmaceuticals, certain of the company’s executives …
Dec 13, 2021 · On 10 November 2021, China saw the landmark decision of its first ever securities class-action. Kangmei Pharmaceuticals, one of China’s largest Chinese medicine producers, was …
Nov 12, 2021 · Investors lost a combined 2.46 billion yuan ($385.26 million), the court said, citing estimates from professional agencies. Shanghai-listed Kangmei was ordered to cover the …
Dec 3, 2021 · On 12 November, the Guangzhou Intermediate People’s Court handed down the first special representative securities action in China against Kangmei Pharmaceutical (Kangmei).
Jan 4, 2022 · Drugs manufacturer Kangmei Pharmaceutical was on 12 November 2021 ordered by the Intermediate People’s Court of Guangzhou to pay investor compensation for a large-scale …
Feb 21, 2025 · On May 13, 2020, due to false records and major omissions in Kangmei Pharmaceutical’s annual and semi-annual reports, the China Securities Regulatory Commission …
Nov 15, 2021 · Kangmei Pharma infringed around 50,000 investors’ rights and interests by making false statements and must pay CNY2.5 billion (USD392 million) in damages, the Guangzhou …
2025-07-04 中证投服中心股东会专项行权圆满完... 2025-05-15 中证投服中心持续打造畅通高效纠纷... 2025-03-31 弘扬新时代“枫桥经验” 中证投服中... 2024-09-03 全国首单操纵市场领域投资者保护 …
In addition, Kangmei Pharmaceutical has been involved in financial fraud for three consecutive years, involving a huge amount of money, lasting for a long time, of a particularly serious nature, …
Mar 28, 2022 · Under the ruling, the publicly listed Kangmei must compensate its shareholders ¥2.459 billion (US$385 million) for making false statements in its annual report.
In November 2021, the Guangzhou Intermediate Court rendered the judgment on the Kangmei Pharmaceutical Co., Ltd. class action case, which marks China’s first securities class action …
Nov 19, 2021 · This action is extraordinary as it is not only the first investor-related victory in China, but the size of the verdict is impressive: it’s large enough to fall within the Top 25 Non-North …
Bài viết được đề xuất: